Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Fecal microbiota alterations are associated with the clinical and endoscopic response to infliximab treatment. A model trained on Lachnospiraceae and Blautia at week 6 showed moderate accuracy to predict clinical and endoscopic response to IFX at weeks 14 and 30 (Zhuang et al. 2020)…